Active — Not RecruitingNot Applicable

Pharmaceutical Care and Quality of Life in Conditions Related to Psychotropic Drug Use

Croatia97 participantsStarted 2021-12-01

Plain-language summary

This study aims to assess and describe the impact of pharmaceutical care on identified drug-related problems (DRPs) in subjects using psycholeptics and psychoanaleptics in primary care, improving subjects' self-assessed quality of life (QoL) The hypothesis of the study are: 1. Side-effects are the most common DRPs in subjects using psychotropic medicines in primary care, 2. Treatment effectiveness and safety affect the subjects´ QoL

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult participants (years 18+) * Usage of psycholeptic or psychoanaleptic medicines * Residence in Istrian County (Croatia) Exclusion Criteria: * Minor participants * Hospitalization during study participation * Unable to live by themselves * Unable to participate in study for 3 months

What they're measuring

Assessment of the quality of life in subjects using psycholeptics and psychoanaleptics

Timeframe: Prior and after the pharmacists' intervention during three months period.

Trial details

NCT IDNCT06889636

SponsorUniversity of Rijeka

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-14

View on ClinicalTrials.gov More Mental Health Services trials